-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D2ukAvvxlbnSVlZP/Q3ynQ6dk6oewKYinj1otm+ep9zbRwMMb41KMrGf0clFlorJ X9m1Okffc2eEN8x5OtLJAA== 0000910680-07-000443.txt : 20070518 0000910680-07-000443.hdr.sgml : 20070518 20070518161523 ACCESSION NUMBER: 0000910680-07-000443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070516 FILED AS OF DATE: 20070518 DATE AS OF CHANGE: 20070518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biodel Inc CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 6 CHRISTOPHER COLUMBUS AVE CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 203-798-3603 MAIL ADDRESS: STREET 1: 6 CHRISTOPHER COLUMBUS AVE CITY: DANBURY STATE: CT ZIP: 06810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KROIN DAVID CENTRAL INDEX KEY: 0001397513 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 07864978 BUSINESS ADDRESS: BUSINESS PHONE: 203-798-3603 MAIL ADDRESS: STREET 1: C/O BIODEL INC STREET 2: 6 CHRISTOPHER COLUMBUS AVENUE CITY: DANBURY STATE: CT ZIP: 06810 4 1 f4kroin_ex.xml DAVID KROIN - FORM 4 X0202 4 2007-05-16 0 0001322505 Biodel Inc BIOD 0001397513 KROIN DAVID C/O BIODEL INC 6 CHRISTOPHER COLUMBUS AVENUE DANBURY CT 06810 1 0 0 0 Common Stock 2007-05-16 4 C 0 1258756 0 A 1966574 I See footnote Common Stock 318 D Series B Convertible Preferred Stock 2007-05-16 4 C 0 1258756 0 D Common Stock 1258756 0 I See footnote Director Stock Option (right to buy) 5.65 2014-07-10 Common Stock 17713 17713 D Director Stock Option (right to buy) 12.63 2014-11-30 Common Stock 2601 2601 D Director Stock Option (right to buy) 15.00 2007-05-10 2017-05-09 Common Stock 25000 25000 D The amount shown represents the beneficial ownership of the Issuer's securities by affiliates of Great Point Partners I, L.P., which may be deemed attributable to the Reporting Person because the Reporting Person is a co-founder and managing director of Great Point Partners I, L.P. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. The Series B Convertible Preferred Stock converted had no expiration date. It was immediately exercisable and was into Common Stock of the Issuer on a one for one basis upon the close of the Issuer's initial public offering. This option is exercisable in two equal installments on July 11, 2007 and July 11, 2008. This option is exercisable in two equal installments on December 1, 2007 and December 1, 2008. /s/ David Kroin 2007-05-17 -----END PRIVACY-ENHANCED MESSAGE-----